Takuo Hayashi

4.6k total citations
211 papers, 2.9k citations indexed

About

Takuo Hayashi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Takuo Hayashi has authored 211 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Pulmonary and Respiratory Medicine, 78 papers in Oncology and 49 papers in Surgery. Recurrent topics in Takuo Hayashi's work include Lung Cancer Treatments and Mutations (36 papers), Sarcoma Diagnosis and Treatment (25 papers) and Cancer Genomics and Diagnostics (18 papers). Takuo Hayashi is often cited by papers focused on Lung Cancer Treatments and Mutations (36 papers), Sarcoma Diagnosis and Treatment (25 papers) and Cancer Genomics and Diagnostics (18 papers). Takuo Hayashi collaborates with scholars based in Japan, United States and United Kingdom. Takuo Hayashi's co-authors include Takashi Yao, Kazuya Takamochi, Tsuyoshi Saito, Kenji Suzuki, Yoshiyuki Suehara, Keiko Mitani, Kazuhisa Takahashi, Shiaki Oh, Kiyoshi Aoyagi and Shinji Kohsaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takuo Hayashi

190 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takuo Hayashi Japan	30	1.4k	967	725	632	379	211	2.9k
Kui Wang China	25	864 0.6×	866 0.9×	1.3k 1.8×	438 0.7×	641 1.7×	72	2.9k
Markus Steinbauer Germany	24	718 0.5×	804 0.8×	967 1.3×	1.1k 1.7×	325 0.9×	86	3.3k
Christoph Mundhenke Germany	28	403 0.3×	906 0.9×	280 0.4×	703 1.1×	399 1.1×	106	2.3k
Wolfgang J. Köstler Austria	31	841 0.6×	1.3k 1.3×	1.4k 1.9×	747 1.2×	281 0.7×	114	3.6k
Cristiana Forni Italy	37	2.8k 2.1×	1.0k 1.1×	1.3k 1.7×	862 1.4×	440 1.2×	106	4.4k
Takashi Ohta Japan	23	827 0.6×	237 0.2×	937 1.3×	407 0.6×	261 0.7×	151	2.1k
John E. Mahoney United States	20	419 0.3×	248 0.3×	321 0.4×	770 1.2×	211 0.6×	31	2.0k
Long Jiang China	26	1.0k 0.7×	513 0.5×	568 0.8×	384 0.6×	254 0.7×	124	2.3k
Fady Geara Lebanon	30	964 0.7×	1.3k 1.4×	938 1.3×	571 0.9×	626 1.7×	103	3.4k
Thomas Winder United States	28	435 0.3×	519 0.5×	435 0.6×	916 1.4×	273 0.7×	108	2.1k

Countries citing papers authored by Takuo Hayashi

Since Specialization

Citations

This map shows the geographic impact of Takuo Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuo Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuo Hayashi more than expected).

Fields of papers citing papers by Takuo Hayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuo Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuo Hayashi. The network helps show where Takuo Hayashi may publish in the future.

Co-authorship network of co-authors of Takuo Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Takuo Hayashi. A scholar is included among the top collaborators of Takuo Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuo Hayashi. Takuo Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Elkrief, Arielle, Igor Odintsov, Roger S. Smith, et al.. (2024). Combination of MDM2 and Targeted Kinase Inhibitors Results in Prolonged Tumor Control in Lung Adenocarcinomas With Oncogenic Tyrosine Kinase Drivers and MDM2 Amplification. JCO Precision Oncology. 8(8). e2400241–e2400241. 3 indexed citations

Mitsuishi, Yoichiro, Wira Winardi, Moulid Hidayat, et al.. (2024). Anti‐Müllerian hormone type II receptor protein expression in non‐small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation. Thoracic Cancer. 15(29). 2090–2099. 1 indexed citations

Aokage, Keiju, Shohei Koyama, Shogo Kumagai, et al.. (2024). Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY). Clinical Cancer Research. 30(24). 5584–5592. 4 indexed citations

Horimoto, Yoshiya, et al.. (2024). Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgery. Japanese Journal of Clinical Oncology. 54(5). 556–561. 1 indexed citations

Hayashi, Takuo, Isamu Watanabe, Kazuya Takamochi, et al.. (2023). Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma. Histopathology. 82(6). 860–869. 13 indexed citations

Miura, Keita, Takehito Shukuya, Sonoko Harada, et al.. (2023). Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines. Cancers. 15(4). 1170–1170. 1 indexed citations

Terao, Yasuhisa, et al.. (2023). Long‐term effect of letrozole on metastatic uterine smooth muscle tumors of uncertain malignant potential: A case report. Journal of obstetrics and gynaecology research. 49(11). 2771–2776. 1 indexed citations

Horimoto, Yoshiya, Hidetaka Eguchi, Katsuya Nakai, et al.. (2023). BRCAness of brain lesions reflects a worse outcome for patients with metastatic breast cancer. Breast Cancer Research and Treatment. 203(1). 49–55. 1 indexed citations

Abe, Yoshiyuki, et al.. (2023). In lupus cystitis, is the urinary tract dilated or obstructed?. Immunity Inflammation and Disease. 11(2). e777–e777. 1 indexed citations

10.

Takamochi, Kazuya, Takuo Hayashi, Aritoshi Hattori, et al.. (2023). Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics. Lung Cancer. 184. 107348–107348. 4 indexed citations

11.

Saito, Tsuyoshi, Daisuke Kubota, Keisuke Akaike, et al.. (2022). Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma. Technology in Cancer Research & Treatment. 21. 2213880105–2213880105. 3 indexed citations

12.

Saito, Tsuyoshi, Takuo Hayashi, Takashi Murakami, et al.. (2020). Molecular and clinicopathological features of colorectal adenocarcinoma with enteroblastic differentiation. Histopathology. 77(3). 492–502. 15 indexed citations

13.

Suehara, Yoshiyuki, Deepu Alex, Anita S. Bowman, et al.. (2019). Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations. Clinical Cancer Research. 25(21). 6346–6356. 98 indexed citations

14.

Hayashi, Takuo, Patrice Desmeules, Roger S. Smith, et al.. (2017). RASA1 and NF1 are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non–Small Cell Lung Carcinomas Sensitive to MEK Inhibition. Clinical Cancer Research. 24(6). 1436–1447. 50 indexed citations

15.

Somwar, Romel, James D. Joseph, Roger S. Smith, et al.. (2016). Antitumor Activity of RXDX-105 in Multiple Cancer Types with RET Rearrangements or Mutations. Clinical Cancer Research. 23(12). 2981–2990. 49 indexed citations

16.

Saito, Tsuyoshi, Yuki Fukumura, Kieko Hara, et al.. (2016). In Japanese patients with papillary thyroid carcinoma, TERT promoter mutation is associated with poor prognosis, in contrast to BRAF V600E mutation. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 469(6). 687–696. 41 indexed citations

17.

Saito, Tsuyoshi, Hiroyuki Mitomi, Takuo Hayashi, et al.. (2014). Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 464(2). 135–143. 33 indexed citations

18.

Suzuki, Kazuhiro, et al.. (2013). Reversed Halo Sign in Tuberous Sclerosis Complex. SHILAP Revista de lepidopterología. 2013. 1–4. 4 indexed citations

19.

Onuma, Akira, Kazuie Iinuma, & Takuo Hayashi. (1978). [Electroencephalographic findings in acute childhood leukemias (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(2). 107–15. 1 indexed citations

20.

Yoshimasu, F, et al.. (1977). [Familial motor neuron disease: Autopsy findings in one of two brothers (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17(7). 439–45. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact